Workflow
Percutaneous Electrical Nerve Field Stimulation (PENFS) technology
icon
Search documents
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones
ZACKS· 2025-05-15 17:11
Shares of NeurAxis, Inc. (NRXS) have gained 13.3% since the company reported its earnings for the quarter ended March 31, 2025. This compares to the S&P 500 Index’s 4.3% growth over the same time frame. Over the past month, the stock gained 39.9% compared with the S&P 500’s 11.6% rise.Revenue and Earnings PerformanceIn the first quarter of 2025, NeurAxis posted revenues of $0.9 million, a 38.5% increase from $0.6 million in the prior-year period. Unit sales grew 46% year over year, largely driven by higher ...